Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)
Fadi Kayali, Muhamad A Janjua, Damian A Laber, Donald Miller, Goetz H KloeckerUniversity of Louisville, James Graham Brown Cancer Center, Louisville, KY, USABackground: In vitro digoxin sensitizes cancer cells to the induction of apoptosis by chemotherapy. Inhibition of the Na/K-ATPase enzyme by oua...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-02-01
|
| Series: | Open Access Journal of Clinical Trials |
| Online Access: | http://www.dovepress.com/phase-ii-trial-of-second-line-erlotinib-and-digoxin-for-nonsmall-cell--a6225 |